Hide Board Information

Show Board Information

Bill The Butcher, Inc. BILB

Board Mod: Hammer_Head

Asst Mods:

Last Post: 07/16/2016 10:11:48 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

Bill The Butcher, Inc. BILB

Bill The Butcher, Inc. (OTCMRKTS: BILB) Stock Message Board

1. BILB Company Profile

    

2. BILB Time & Sales

    

3. BILB Recent News

    

4. BILB Filings

    

5. BILB Financials

    

6. BILB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	https://nvsos.gov/sosentitysearch/corpActions.asp	pennybuster	07/16/2016 10:11:48 PM
6	Wow, this board's really active. No post since	energy_wave	06/07/2016 3:44:43 AM
5	BILB Financials 07/15/2014 23:50:44 Bill The	Emylers	07/16/2014 12:50:41 AM
4	Latest Bill The Butcher Inc. (BILB) Headlines	Stock_Tracker	03/09/2014 1:38:29 AM
3	BILB 0.17 Stock Charts $BILB 1 Month Chart	chartguy89	03/06/2014 2:51:47 AM
2	BILB Recent News Cypress's TrueTouch(R)	Stock_Tracker	03/03/2014 12:48:55 AM
1	BILB Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 8:26:55 AM

Recent Articles

• Ascentage Pharma Showcases Long-Term Efficacy Data for Olverembatinib
• Promising Results from Phase III POLARIS-1 Study of Olverembatinib
• Promising New Data on Olverembatinib for CML Treatment
• Promising Update on Olverembatinib for CML-CP Patients
• Olverembatinib's Significant Long-Term Impact for CML Patients
• CoreWeave, Inc.: Investigating Claims and Market Impact
• Hong Kong Rallies Together to Rebuild After Tragic Fire
• RetinalGenix Welcomes M. Cory Zwerling as New CFO and Interim COO
• Star Group, L.P. Sees Growth in 2025 Financial Results
• Star Group, L.P. Achieves Revenue Growth in Fiscal 2025
• Shaquille O'Neal's Innovative Journey from Basketball to Tech
• BioArctic's Leqembi Listed as Innovative Drug in China
• Innovent Biologics Delivers Breakthrough in Psoriasis Treatment
• Vermilion Energy Expands Financial Strategy Through Share Sales
• Morgan Dudley Joins Stargaze as Creative Advisor for New Era
• Understanding the Securities Class Action for Telix Pharmaceuticals
• Trump's Involvement in Paramount's Bid for Warner Bros. Discovery
• Investing in Deutsche Bank: Strong Returns Over Five Years
• Transform Your Investment: The Journey of $1000 in OEF Growth
• BioArctic's Leqembi Approved for China's Innovative Drug List
• Urgent Call for Global Health Funding to Prevent Child Deaths
• LEQEMBI's Inclusion in China's Innovative Drug List: Impact and Future
• Important Update for Synopsys Investors on Class Action Steps
• JAX's $30 Million Initiative to Transform Drug Safety Testing
• Discover the Growth of a $1000 Investment in Stryker Today
• Gates Foundation Calls for Action to Combat Child Mortality Rise
• Exciting Growth for Club Med: New Resort at Tremblant
• Kia PV5 Cargo: Leading the Charge in Commercial Van Safety
• Todd Warrick Takes Charge as Triangle Market President
• Trulieve Secures Major Funding with US$100 Million Notes Offering
• Innovative AI Project by Jackson Laboratory to Improve Drug Safety
• Ilene Fennoy, MD Recognized as Leader in Pediatric Healthcare
• James W. Edlund, MD: Celebrating a Legacy of Wound Care
• FOMC's Rate Decision and Major Earnings Reports Ahead
• Paramount Steps Up to Challenge Netflix Over Warner Bros Deal
• Investors Urged to Act: Fiserv Class Action Lawsuit Update
• TDECU Welcomes New Directors for Enhanced Leadership Team
• Investors Urged to Join Class Actions Against DexCom and CarMax
• Urgent Notice for James Hardie Industries plc Investors
• Imviva Biotech's Breakthrough CAR-T Therapies: Highlights and Insights
• Secure Your Rights: Join the Wildermuth Fund Class Action Today
• AI UltraProd Ventures into U.S. Market with Innovative ADU Solutions
• Significant Growth: How $100 in TJX Companies Has Multiplied
• Gene Munster's Top Apple Predictions for Stock Performance
• Transforming $100 Into a Fortune: Dell Technologies' Growth
• Lundin Gold's Strategic Growth and Production Goals for 2026
• GoldMining Revamps Equity Program to Boost Financial Growth
• Ares Management Joins S&P 500; Changes in SmallCap 600
• Understanding the Class Action Suit Against Johnson & Johnson
• Independent Nominees for Lynx1 Gain Advisory Support